U.S. Employer And Workplace Drug Testing Market Size, Share & Trends Analysis Report By Type (Pre-employment Drug Screens), By Product, By Mode, By Drug, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Market Definitions
                        1.2.1. Type Segment
                        1.2.2. Product Segment
                        1.2.3. Mode Segment
                        1.2.4. Drug Segment
                        1.2.5. End Use Segment
                    1.3. Information analysis
                        1.3.1. Market formulation & data visualization
                    1.4. Data validation & publishing
                    1.5. Information Procurement
                        1.5.1. Primary Research
                    1.6. Information or Data Analysis
                    1.7. Market Formulation & Validation
                    1.8. Market Model
                    1.9. Total Market: CAGR Calculation
                    1.10. Objectives
                        1.10.1. Objective 1
                        1.10.2. Objective 2
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Insights Landscape
Chapter 3. U.S. Employer and Workplace Drug Testing Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook.
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                            3.3. U.S. Employer and Workplace Drug Testing Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                        3.3.2. PESTEL Analysis
                        3.3.3. COVID-19 Impact Analysis
Chapter 4. U.S. Employer and Workplace Drug Testing Market: Type Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. Employer and Workplace Drug Testing Market Type Movement Analysis
                    4.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
                    4.4. Pre-employment Drug Screens
                        4.4.1. Pre-employment drug screens market estimates and forecasts 2018 to 2030 (USD Million)
                    4.5. Post-employment
                        4.5.1. Post-employment market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Employer and Workplace Drug Testing Market: Product Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. Employer and Workplace Drug Testing Market Product Movement Analysis
                    5.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
                    5.4. Consumables
                        5.4.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
                    5.5. Instruments
                        5.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
                    5.6. Rapid Testing Devices
                        5.6.1. Rapid testing devices market estimates and forecasts 2018 to 2030 (USD Million)
                    5.7. Services
                        5.7.1. Services market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Employer and Workplace Drug Testing Market: Mode Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. U.S. Employer and Workplace Drug Testing Market Mode Movement Analysis
                    6.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Mode, 2018 to 2030 (USD Million)
                    6.4. Urine
                        6.4.1. Urine market estimates and forecasts 2018 to 2030 (USD Million)
                    6.5. Hair
                        6.5.1. Hair market estimates and forecasts 2018 to 2030 (USD Million)
                    6.6. Oral Fluid
                        6.6.1. Oral fluid market estimates and forecasts 2018 to 2030 (USD Million)
                    6.7. Instant testing
                        6.7.1. Instant testing market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Employer and Workplace Drug Testing Market: Drug Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. U.S. Employer and Workplace Drug Testing Market Drug Movement Analysis
                    7.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Drug, 2018 to 2030 (USD Million)
                    7.4. Alcohol
                        7.4.1. Alcohol market estimates and forecasts 2018 to 2030 (USD Million)
                    7.5. Cannabis/Marijuana
                        7.5.1. Cannabis/marijuana market estimates and forecasts 2018 to 2030 (USD Million)
                    7.6. Cocaine
                        7.6.1. Cocaine market estimates and forecasts 2018 to 2030 (USD Million)
                    7.7. Opioids
                        7.7.1. Opioids testing market estimates and forecasts 2018 to 2030 (USD Million)
                    7.8. Amphetamine & Methamphetamine
                        7.8.1. Amphetamine & methamphetamine market estimates and forecasts 2018 to 2030 (USD Million)
                    7.9. LSD
                        7.9.1. LSD market estimates and forecasts 2018 to 2030 (USD Million)
                    7.10. Others
                        7.10.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. U.S. Employer and Workplace Drug Testing Market: End Use Estimates & Trend Analysis
                    8.1. Segment Dashboard
                    8.2. U.S. Employer and Workplace Drug Testing Market End Use Movement Analysis
                    8.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
                    8.4. IT/Finance
                        8.4.1. IT/finance market estimates and forecasts 2018 to 2030 (USD Million)
                    8.5. Manufacturing
                        8.5.1. Manufacturing market estimates and forecasts 2018 to 2030 (USD Million)
                    8.6. Transportation
                        8.6.1. Transportation market estimates and forecasts 2018 to 2030 (USD Million)
                    8.7. Construction
                        8.7.1. Construction market estimates and forecasts 2018 to 2030 (USD Million)
                    8.8. Retail and Hospitality
                        8.8.1. Retail and hospitality market estimates and forecasts 2018 to 2030 (USD Million)
                    8.9. Healthcare
                        8.9.1. Healthcare market estimates and forecasts 2018 to 2030 (USD Million)
                    8.10. Education
                        8.10.1. Education surgical centers market estimates and forecasts 2018 to 2030 (USD Million)
                    8.11. Other Professional Services
                        8.11.1. Other Professional Services market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
                    9.1. Company/Competition Categorization
                    9.2. Strategy Mapping
                    9.3. Company Market Position Analysis, 2023
                    9.4. List of Key Certification Providers/Scheme Owners
                    9.5. Company Profiles/Listing
                        9.5.1. First Advantage
                            9.5.1.1. Company overview
                            9.5.1.2. Financial performance
                            9.5.1.3. Product benchmarking
                            9.5.1.4. Strategic initiatives
                        9.5.2. Laboratory Corporation of America Holdings (Labcorp)
                            9.5.2.1. Company overview
                            9.5.2.2. Financial performance
                            9.5.2.3. Product benchmarking
                            9.5.2.4. Strategic initiatives
                        9.5.3. Drägerwerk AG & Co. KGaA
                            9.5.3.1. Company overview
                            9.5.3.2. Financial performance
                            9.5.3.3. Product benchmarking
                            9.5.3.4. Strategic initiatives
                        9.5.4. Bio-Rad Laboratories, Inc.
                            9.5.4.1. Company overview
                            9.5.4.2. Financial performance
                            9.5.4.3. Product benchmarking
                            9.5.4.4. Strategic initiatives
                        9.5.5. Abbott
                            9.5.5.1. Company overview
                            9.5.5.2. Financial performance
                            9.5.5.3. Product benchmarking
                            9.5.5.4. Strategic initiatives
                        9.5.6. Clinical Reference Laboratory Inc.
                            9.5.6.1. Company overview
                            9.5.6.2. Financial performance
                            9.5.6.3. Product benchmarking
                            9.5.6.4. Strategic initiatives
                        9.5.7. Quest Diagnostics
                            9.5.7.1. Company overview
                            9.5.7.2. Financial performance
                            9.5.7.3. Product benchmarking
                            9.5.7.4. Strategic initiatives
                        9.5.8. Cordant Health Solutions
                            9.5.8.1. Company overview
                            9.5.8.2. Financial performance
                            9.5.8.3. Product benchmarking
                            9.5.8.4. Strategic initiatives
                        9.5.9. DISA Global Solutions
                            9.5.9.1. Company overview
                            9.5.9.2. Financial performance
                            9.5.9.3. Product benchmarking
                            9.5.9.4. Strategic initiatives
                        9.5.10. HireRight, LLC
                            9.5.10.1. Company overview
                            9.5.10.2. Financial performance
                            9.5.10.3. Product benchmarking
                            9.5.10.4. Strategic initiatives
                        9.5.11. OraSure Technologies, Inc.
                            9.5.11.1. Company overview
                            9.5.11.2. Financial performance
                            9.5.11.3. Product benchmarking
                            9.5.11.4. Strategic initiatives
                        9.5.12. Psychemedics Corporation
                            9.5.12.1. Company overview
                            9.5.12.2. Financial performance
                            9.5.12.3. Product benchmarking
                            9.5.12.4. Strategic initiatives
                        9.5.13. Omega Laboratories
                            9.5.13.1. Company overview
                            9.5.13.2. Financial performance
                            9.5.13.3. Product benchmarking
                            9.5.13.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 U.S. employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
Table 3 U.S. employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
Table 4 U.S. employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
Table 5 U.S. employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
Table 6 U.S. employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. employer and workplace drug testing market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 U.S. employer and workplace drug testing market: Type outlook key takeaways
Fig. 20 U.S. employer and workplace drug testing market: Type movement analysis
Fig. 21 Pre-employment drug screens market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Post-employment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 U.S. employer and workplace drug testing market: Product outlook key takeaways
Fig. 24 U.S. employer and workplace drug testing market: Product movement analysis
Fig. 25 Consumables market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Rapid testing devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 U.S. employer and workplace drug testing market: Mode outlook key takeaways
Fig. 30 U.S. employer and workplace drug testing market: Mode movement analysis
Fig. 31 Urine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Hair market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Oral fluid market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Instant testing estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 U.S. employer and workplace drug testing market: Mode outlook key takeaways
Fig. 36 U.S. employer and workplace drug testing market: Mode movement analysis
Fig. 37 Alcohol market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Cannabis/marijuana market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Cocaine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Opioids estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Amphetamine & methamphetamine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 LSD market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 U.S. employer and workplace drug testing market: End use outlook key takeaways
Fig. 45 U.S. employer and workplace drug testing market: End use movement analysis
Fig. 46 IT/finance market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Transportation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Construction estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Retail and hospitality market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Healthcare market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Education market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Other professional services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Market participant categorization
Fig. 55 U.S. employer and workplace drug testing market position analysis, 2023
Fig. 56 Strategic framework